Protein phosphorylation has become increasingly recognized for its role in regulating bacterial physiology and virulence. Chlamydia spp. encode two validated Hanks'-type Ser/Thr protein kinases, which typically function with cognate protein phosphatases and appear capable of global protein phosphorylation. Consequently, we sought to identify a Ser/Thr protein phosphatase partner for the chlamydial kinases. CTL0511 from Chlamydia trachomatis L2 434/Bu, which has homologs in all sequenced Chlamydia spp., is a predicted type 2C Ser/Thr protein phosphatase (PP2C). Recombinant maltose-binding protein (MBP)-tagged CTL0511 (rCTL0511) hydrolyzed p-nitrophenyl phosphate (pNPP), a generic phosphatase substrate, in a MnCl 2 -dependent manner at physiological pH. Assays using phosphopeptide substrates revealed that rCTL0511 can dephosphorylate phosphorylated serine (P-Ser), P-Thr, and P-Tyr residues using either MnCl 2 or MgCl 2 , indicating that metal usage can alter substrate preference. Phosphatase activity was unaffected by PP1, PP2A, and PP3 phosphatase inhibitors, while mutation of conserved PP2C residues significantly inhibited activity. Finally, phosphatase activity was detected in elementary body (EB) and reticulate body (RB) lysates, supporting a role for protein dephosphorylation in chlamydial development. These findings support that CTL0511 is a metal-dependent protein phosphatase with broad substrate specificity, substantiating a reversible phosphorylation network in C. trachomatis.
C
hlamydia spp. are obligate intracellular bacterial pathogens that are widely distributed in nature and are responsible for significant diseases in humans and a variety of animals (1, 2) . The human-specific pathogen Chlamydia trachomatis is the leading cause of preventable blindness and the most common reportable bacterial sexually transmitted infection both in the United States and worldwide (3, 4) . C. trachomatis infections of the conjunctiva and the urogenital tract may lead to chronic diseases, including trachoma, pelvic inflammatory disease, and infertility (1) . Further understanding of the physiology of these highly significant pathogens is critical for developing therapeutics and vaccines.
While Chlamydia spp. differ in host range and virulence, all species undergo a similar biphasic developmental cycle that involves two morphologically distinct forms, the elementary body (EB) and the reticulate body (RB) (5, 6) . The environmentally stable and infectious EB attaches to the surface of a mucosal epithelial cell and triggers endocytosis, possibly facilitated by the chlamydial type III secretion system (7) . Following internalization, the EB differentiates into the larger metabolically active and replicative RB form within a host-derived membrane vacuole termed the inclusion. The RBs propagate via binary fission, differentiate back into EBs, and then exit the host by cell lysis or inclusion extrusion (8) . The cues triggering and mechanisms facilitating EB-to-RB and RB-to-EB differentiation remain largely unknown.
Reversible phosphorylation of proteins is a posttranslational regulatory mechanism involved in multiple complex processes, including cell signaling, growth, and differentiation, in both eukaryotes and prokaryotes (9, 10 ). Regulation at the molecular level is mediated by the addition or removal of a phosphate group from select amino acids (typically Ser, Thr, Tyr, His, and Asp) by the opposing actions of protein kinases and their cognate phosphatases serving to modulate the activity, interactions, and localization of target proteins (11, 12) . Phosphorylation of protein substrates can lead to direct modulation of protein function or alteration of gene expression on a global level, in the case of activation of transcription factors or signaling pathways (13) . In bacteria, Ser, Thr, and Tyr protein phosphorylation, which was once considered to be exclusive to eukaryotes, has gained increasing attention due to its role in major cellular events, including regulation of virulence, stress responses, and differentiation (11, (14) (15) (16) (17) .
Phosphorylation of Ser, Thr, and Tyr residues in bacteria is typically catalyzed by Hanks'-type kinases (also known as eukaryotic-like kinases) and bacterial tyrosine (BY) kinases, respectively (18) . Findings from multiple studies support a role for protein phosphorylation in chlamydial physiology. Chlamydia spp. encode two validated (Pkn1 and PknD) and one putative (Pkn5) Hanks'-type kinases (19, 20) . Phosphoproteomic analysis of Chlamydia caviae identified 42 phosphoproteins that are present in a developmental stage-specific pattern, with EBs containing 3-fold more phosphoproteins than RBs (21) . Among the 42 phosphoproteins identified, 41 have homologs in C. trachomatis and other Chlamydia species. Further substantiating the essentiality of protein phosphorylation to chlamydial physiology, a Chlamydia pneumoniae PknD-specific inhibitor prevented bacterial growth in cell culture, and a forward genetic screen with C. trachomatis failed to obtain nonsense pkn1 and pknD mutants (22, 23) .
In this report, we sought to identify a protein phosphatase that could act as a partner for Pkn1 and/or PknD to complete a reversible phosphorylation network in Chlamydia. We have demonstrated that CTL0511 from C. trachomatis L2 434/Bu acts as a type 2C protein phosphatase (PP2C), a member of the metal-dependent protein phosphatase family (PPM). A multiple-sequence alignment of CTL0511 with characterized PP2Cs revealed the presence of conserved features shared within this family of phosphatases, including all critical catalytic amino acids. The metaldependent catalytic activity of CTL0511 was confirmed and further assessed using both p-nitrophenyl phosphate (pNPP) and phosphopeptides as substrates. In addition, mutation of PP2C-conserved residues resulted in a loss of activity, and non-PP2C inhibitors did not reduce phosphatase activity. The presence of phosphatase activity in EB and RB lysates was also demonstrated. The validation of a functional Chlamydia-conserved PP2C completes the protein phosphorylation circuit, further supporting the presence of a reversible phosphorylation network.
MATERIALS AND METHODS
Cell and bacterial culture conditions. L2 mouse fibroblasts were maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and incubated at 37°C with 5% CO 2 . C. trachomatis L2 434/Bu was passaged in L2 mouse fibroblasts, as previously described (24) . C. trachomatis EBs were harvested via centrifugation and stored in sucrose phosphate-buffered glutamic acid at Ϫ80°C. The titers of the chlamydial stocks were determined using the inclusion-forming unit assay (25) . Escherichia coli DH5␣ was used for routine cloning procedures, and E. coli NEB Express (New England BioLabs) was used for protein production. All strains were cultured in lysogeny broth (LB) or on LB agar plates at 37°C with 100 g/ml ampicillin.
Construction of MBP-tagged recombinant CTL0511 and site-directed mutants. Genomic DNA was isolated from C. trachomatis L2 434/Bu EBs using the DNeasy blood and tissue kit, as directed by the manufacturer (Qiagen). CTL0511 was amplified by PCR with Phusion polymerase (Thermo Scientific) using primers MAL511F (AATTCGGAT CCATTGTTGCGGATTTC, BamHI site underlined) and MAL511R (TG CAGGTCGACTTAACGCATCCGAACC, SalI site underlined). The PCR product was digested with BamHI and SalI and ligated into a similarly digested pMAL-c4X (New England BioLabs) to create an N-terminal maltose-binding protein (MBP)-CTL0511 fusion protein. Ligation products were transformed into E. coli DH5␣ and selected on LB agar plates with ampicillin. Transformants were screened by colony PCR (primers pMALE, TCAGACTGTCGATGAAGC; and pUCR, GGTTTTCCCAGTC ACGACGTTG). A CTL0511-postive transformant was then grown for plasmid isolation (designated pMAL511) and sequencing of the CTL0511 gene insert (Sanger sequencing performed by Macrogen USA).
For site-directed mutagenesis of the PP2C conserved aspartates, 5=-phosphorylated primers R511-38/511D38N (AGCTGCGAATCATAGTT TACC/CATTGCCATTGCAAACGGAATGGGAGGTC, mutation underlined) and R511-199/511D199N (AAATAGGTCTTCTTTCTCATAA G/GTTTTTTGTTCTAATGGTCTAACTAGTG, mutation underlined) were used in PCRs with Phusion polymerase and 100 pg of pMAL511 to create a D38N mutant (pMAL511D38N) and a D199N mutant (pMAL511D199N). PCR products were gel purified, ligated, and transformed into E. coli DH5␣. Transformants were selected on LB agar with ampicillin and grown for plasmid isolation. DNA sequencing of the CTL0511 insert was utilized to confirm the presence of the desired mutations. For protein expression, all plasmids were transformed into E. coli NEB Express to create strains DF634 (carrying pMAL511), DF686 (carrying pMAL511D38N), and DF687 (carrying pMAL511D199N). All clones were designed using Clone Manager software (Scientific and Educational Software), and sequencing results were analyzed using BioEdit (26) .
Expression and affinity purification of rCTL0511. DF634, DF674 (pMAL-c4x empty vector control strain), DF686, and DF687 were grown in 150 ml of LB supplemented with ampicillin and 0.2% glucose at 37°C with shaking to an optical density at 600 nm (OD 600 ) of 0.5. Cultures were cooled to 18°C, and the expression of rCTL0511 was induced with 0.3 mM isopropyl ␤-D-1-thiogalactopyranoside for 20 h at 18°C with shaking. Cells were then harvested by centrifugation at 13,000 ϫ g for 10 min at 4°C. Pellets were stored at Ϫ20°C overnight and then suspended in lysis buffer (20 mM Tris-HCl [pH 8], 500 mM NaCl, 10 mM imidazole, 0.1% Triton X-100, 10% glycerol, and Thermo Scientific Halt EDTA-free protease inhibitor cocktail). The cells were disrupted via sonication and then centrifuged at 13,000 ϫ g for 10 min at 4°C to remove debris. Supernatants were filtered using a 0.45-m-pore-size filter, and rCTL0511 was affinity purified using amylose resin (New England BioLabs). The rCTL0511 eluates were pooled and concentrated in storage buffer (20 mM Tris-HCl [pH 8], 100 mM NaCl, 1 mM dithiothreitol [DTT] , and 10% glycerol) using Amicon Ultra-15 centrifugal filters (Millipore). Purified rCTL0511 was quantified using the Bio-Rad protein assay kit, and 10 g/l aliquots were stored at Ϫ20°C. All protein preparations were analyzed for purity using 12% SDS-PAGE gels stained with Coomassie brilliant blue and assessed for identity using Western blotting with mouse monoclonal anti-MBP antibodies (diluted 1:1,000; New England BioLabs) and goat anti-mouse IgG horseradish peroxidase (HRP)-conjugated antibodies (diluted 1:1,000; Millipore). The Western blots were developed with chemiluminescent substrate (Immobilon ECL; EMD Millipore) and imaged using a Bio-Rad ChemiDoc MP. Blots and gel images were processed and analyzed using the Image Lab software (BioRad).
RB harvest. RBs were harvested as previously described by Fisher et al. (21) , with minor modifications. Briefly, eight T175 flasks were infected at a multiplicity of infection (MOI) of ϳ10, and infections were allowed to proceed for 15 h. The infected cells were then dislodged with beads, lysed using a dounce homogenizer, and RBs were isolated using ultracentrifugation with discontinuous gradients of Percoll Plus (GE Healthcare). A protease inhibitor cocktail was used throughout RB purification (4-methylumbelliferyl phosphate [MUP]-based phosphatase assays with rCTL0511 demonstrated that the protease inhibitors did not affect phosphatase activity). RBs were then immediately lysed in phosphatase assay buffer, and the protein concentration was determined using the Bio-Rad protein assay. The samples were then taken for SDS-PAGE, Western blotting, and MUP-based phosphatase assays.
SDS-PAGE and Western blot analysis of EB and RB preparations. Following protein quantification, 5 g of EB and RB preparations were solubilized in Laemmli buffer and analyzed for total protein using 12% SDS-PAGE gels stained with Coomassie brilliant blue. For Western blot analysis, mouse monoclonal anti-major outer membrane protein (anti-MOMP) (1:1,000 dilution; Abcam) and rabbit polyclonal anti-TarP (1:200; provided by Raphael Valdivia, Duke University, Durham, NC [27] ) primary antibodies were used. Following SDS-PAGE with 10 g of EB and RB preparations, the proteins were transferred to nitrocellulose membranes and blocked in 5% milk Tris-buffered saline (MTBS). The membranes were then incubated with primary antibodies, washed with 0.5% Tween 20 Tris-buffered saline (TTBS), and incubated with either goat anti-mouse or goat anti-rabbit IgG HRP-conjugated antibodies. The membranes were developed with chemiluminescent substrate (Immobilon ECL; EMD Millipore) and imaged using a Bio-Rad ChemiDoc MP. Images were processed and analyzed using the Image Lab software (BioRad).
Phosphatase assays. (i) pNPP. Unless specified, 16.5 mg of pNPP was dissolved in 50 l of distilled H 2 O to give a 100ϫ solution and then added to the assay buffer containing 50 mM Tris-HCl (pH 7.5), 50 mM KCl, 25 mM MnCl 2 , and 1 mM DTT to a final concentration of 4.4 mM. Six micrograms of purified recombinant protein (wild type or mutant) was added to the well in duplicate, and the reaction was initiated by addition of the assay buffer with pNPP. The release of p-nitrophenol (pNP) was measured at A 405 every 5 min for 90 min in a 96-well plate reader (Synergy HT; BioTek) at 37°C. Specific activity is defined as concentration (nmol) pNP released ϫ min Ϫ1 ϫ mg of protein Ϫ1 , and the amount of pNP was calculated using a molar extinction coefficient of 18,500 M Ϫ1 cm Ϫ1 . To determine metal dependence, rCTL0511 activity was measured using assay buffers containing 25 mM MgCl 2 , 25 mM MnCl 2 , or no metal. Optimal MnCl 2 concentrations were determined using assay buffers with varied concentrations of MnCl 2 (0 to 35 mM). Finally, the effect of pH on activity was assessed by assaying phosphatase activity in 50 mM Tris-HCl (pH 7 to 9) or glycine-NaOH (pH 9.5 to 10). The pH phosphatase assays were performed using assay buffers containing 10 mM pNPP and 0.5 mM MnCl 2 to prevent metal oxide formation.
To determine the kinetic parameters of rCTL0511, initial reaction velocities were measured using assay buffer (pH 8) containing various pNPP concentrations (0.02 to 50 mM) at saturating levels of MnCl 2 (20 mM). The saturating MnCl 2 concentration with 3 g of protein at pH 8 was determined by measuring the phosphatase activity over a range of MnCl 2 concentrations (10 to 30 mM) with a fixed 5 mM pNPP concentration. The reactions were initiated by the addition of 3 g of protein, and pNP release was measured every 2 min. Kinetic constants were determined by nonlinear regression analysis using the GraphPad Prism 5 software.
(ii) Synthetic phosphopeptides. To determine substrate specificity, phosphatase assays were performed using synthetic phosphopeptide substrates. 2 . The reactions were initiated by adding 3 g of rCTL0511, incubated at 37°C for 60 min, and then terminated by adding 100 l of Biomol Green reagent (Enzo). The plate was then incubated for 20 min at room temperature to allow for color development. The amount of phosphate released was measured at A 620 and determined using a standard curve generated with free phosphate (P i ). As a negative control, assays were also performed with 3 g of MBP and each phosphopeptide. The A 620 values from the MBP experiments were subtracted from those of the corresponding rCTL0511 assay.
(iii) MUP. The phosphatase reaction mixtures contained 50 mM TrisHCl (pH 8), 50 mM KCl, 25 mM MnCl 2 , 1 mM DTT, and 1 mM 4-methylumbelliferyl phosphate (MUP) (Thermo Scientific) in a total volume of 100 l. EBs and RBs from C. trachomatis were suspended in lysis buffer and sonicated using 5-s pulses. The lysates were immediately quantified using the Bio-Rad protein assay kit and assayed for phosphatase activity. EB and RB lysates (50 g and 100 g) were diluted to a final volume of 50 l, transferred to a 96-well plate, and reactions were initiated by adding 50 l of 2ϫ assay buffer. For controls, 1 g of either rCTL0511 or MBP was transferred to a well, and the reaction was initiated by adding 1ϫ assay buffer. Fluorescence was measured at an excitation of 360 nm and an emission of 440 nm every 5 min for 90 min at 37°C.
(iv) Phosphatase inhibitor studies. Phosphatase activity was measured in the presence of phosphatase inhibitors okadaic acid (Sigma), cyclosporine (Torcis), or sodium pyrophosphate (Sigma). Okadaic acid and cyclosporine were dissolved in dimethyl sulfoxide (DMSO) to yield 0.5 mM stocks, and sodium pyrophosphate was dissolved in assay buffer (50 mM Tris-HCl [pH 7.5], 50 mM KCl, and 1 mM DTT) to yield a 50 mM stock. Six micrograms of rCTL0511 was transferred to a well and incubated with 36 M okadaic acid, 36 M cyclosporine, 10 mM sodium pyrophosphate, or DMSO for 5 min. Reactions were initiated by adding assay buffer containing pNPP to a final volume of 100 l. Phosphatase activity was measured at A 405 every 5 min for 90 min at 37°C.
RESULTS
Amino acid sequence analysis of CTL0511 versus PP2C homologs. CTL0511 encodes a predicted Ser/Thr protein phosphatase with homology to the PP2C family and consists of 248 amino acids (27 kDa; pI ϭ 5.19). CTL0511 displayed between 91 and 51% sequence identity with the PP2C homolog from all Chlamydia species, with the highest identity with Chlamydia muridarum and lowest identity with Chlamydia pecorum (the values in the range mentioned above, respectively). As indicated in Fig. 1 , the conserved features of the PP2C family of phosphatases are present in CTL0511 and all other chlamydial homologs. The eight absolutely conserved residues, noted in Fig. 1 by triangles, are involved in substrate recognition, metal coordination, and catalysis and are dispersed across 11 signature motifs (11, (28) (29) (30) . The amino acids within regions VB and VI comprise a flap region predicted to function in substrate recognition (31) .
Expression and purification of rCTL0511. To assess catalytic activity, CTL0511 was cloned in frame with the malE gene to create an N-terminal MBP-CTL0511 fusion protein, here referred to as rCTL0511. The rCTL0511 and MBP (control protein) were affinity purified using amylose resin. SDS-PAGE analysis with Coomassie brilliant blue staining of rCTL0511 and MBP pooled elution fractions revealed prominent bands corresponding to 71 and 43 kDa, respectively, and were determined to be Ͼ90% pure (see Fig. S1A and B in the supplemental material). Furthermore, the major bands were detected by anti-MBP Western blot analysis and matched the calculated molecular weight of rCTL511 or MBP (see Fig. S1C in the supplemental material) . Following affinity purification, proteins were dialyzed and stored in buffer lacking divalent metals.
CTL0511 metal requirement, pH sensitivity, and kinetics. PP2C phosphatases belong to the metal-dependent family of protein phosphatases (PPM), which are dependent on either Mg 2ϩ or Mn 2ϩ ions for catalysis (32) (33) (34) (35) . Using the generic phosphatase substrate pNPP, phosphatase activity was measured in the absence of divalent metal ions and in the presence of either MnCl 2 or MgCl 2 . When phosphatase activity was tested in the absence of metal or in the presence of 25 mM MgCl 2 , the formation of the product, pNP, was not detected. In contrast, pNPP hydrolysis was observed in the presence of 25 mM MnCl 2 ( Fig. 2A) . Additionally, phosphatase activity was not detected in the presence of the divalent cations Ca 2ϩ , Co 2ϩ , and Zn 2ϩ (data not shown). The control MBP sample lacked detectable levels of phosphatase activity under all conditions tested. To determine the optimal MnCl 2 concentration for phosphatase activity for subsequent studies and to further investigate Mn 2ϩ utilization, assays were performed in the presence of increasing concentrations of MnCl 2 . Phosphatase activity increased in a concentration-dependent manner from 5 mM to 25 mM MnCl 2 (Fig. 2B) .
The pH sensitivity of rCTL0511 was also assessed to further determine the optimal conditions for rCTL0511 phosphatase activity. Since MnCl 2 undergoes metal hydroxide formation at alkaline pH, we performed phosphatase assays using 0.5 mM MnCl 2 and 10 mM pNPP. Phosphatase activity was detectable at pH 7 and increased 3-fold at pH 7.5 (Fig. 2C) . Optimal phosphatase activity was observed at pH 8. Taken together, these results demonstrate that rCTL0511 is Mn 2ϩ dependent and functions at physiological pH (7.2 to 7.4) when pNPP is the substrate (36) .
To determine whether rCTL0511 catalytic activity was similar to that of other PP2Cs, enzyme kinetics were assessed with pNPP (Fig. 3) . Consistent with other PP2Cs, rCTL0511 exhibits a K m and k cat of 0.95 Ϯ 0.21 mM and 8.4 Ϯ 0.40 s Ϫ1 , respectively (28, 34, (37) (38) (39) (40) (41) (42) (43) . Other previously reported kinetic values ranged from 0.35 to 5.7 mM pNPP for K m and 0.10 to 7.4 s Ϫ1 for k cat (Table 1) .
Phosphatase activity of mutant rCTL0511 using pNPP as a substrate. The multiple-sequence alignment (Fig. 1) revealed that CTL0511 contains eight absolutely conserved residues, including four aspartate residues implicated in metal coordination. Previous studies have shown that mutations in these residues lead to an abrogation in phosphatase activity (14, 28) . To investigate the mechanistic relevance of these residues in rCTL0511, we performed site-directed mutagenesis to generate D38N and D199N amino acid substitutions (Fig. 1 ). These mutant proteins were then assayed for activity, and both mutations abolished Mn 2ϩ -dependent pNPP hydrolysis (Fig. 4) .
Effect of phosphatase inhibitors on rCTL0511. To further support the in silico designation of CTL0511 as a PP2C, we performed phosphatase assays in the presence of phosphatase inhibitors that target different classes within the Ser/Thr protein phosphatase family. Okadaic acid inhibits PP1 (50% inhibitory concentration [IC 50 ], 49 nM to 147 nM) and PP2A (IC 50 , 0.28 nM to 4.7 nM) phosphatases, while cyclosporine (IC 50 , 10 nM to 40 nM) inhibits PP3 phosphatases (44) (45) (46) (47) (48) . Phosphatase activity was , and Synechocystis PCC 6803 (S; PphA) using Clustal Omega and processed using BioEdit. Identical residues are highlighted in black, and conserved residues are highlighted in gray using a 100% shading threshold. The eight absolute conserved residues (hallmarks of PP2Cs) are indicated with triangles. The signature motifs of the PP2C family are represented by roman numerals, in accordance with the convention of Shi et al. (29) . Critical residues involved in catalysis are denoted by asterisks. Arrows indicate aspartic acids mutated in this study (D38N and D199N).
also assayed in the presence of sodium pyrophosphate, an irreversible inhibitor of Ser/Thr protein phosphatases typically used at a final concentration of 1 mM to 10 mM (34, 37) . The presence of either okadaic acid or cyclosporine at levels Ͼ200-fold above their respective IC 50 did not inhibit phosphatase activity in comparison to the DMSO control (Fig. 5.) . In contrast, sodium pyrophosphate completely abolished phosphatase activity. DMSO (used to dissolve okadaic acid and cyclosporine) did not alter phosphatase activity compared to the assay buffer alone (data not shown). These data demonstrated that CTL0511 was not of the PP1, PP2A, and PP3 classes and further support the assignment of CTL0511 as a PP2C.
Substrate specificity of CTL0511. To determine rCTL0511 substrate specificity, assays were performed using phosphorylated serine (P-Ser) [RRA(pS)VA], P-Thr [KR(pT)IRR], and two PTyr [RRLIEDAE(pY)AARG and TSTEPQ(pY)QPGENL] peptide substrates. rCTL0511 dephosphorylated both P-Ser and PThr residues in the presence of 25 mM MnCl 2 , releasing 2-fold more inorganic phosphate using the P-Thr substrate (Fig. 6A) . While CTL0511, as a PP2C, was predicted to be specific for P-Ser and P-Thr residues, our results show that rCTL0511 was also capable of dephosphorylating P-Tyr peptides at levels similar to those of the P-Ser peptide. To determine whether Mg 2ϩ had an effect on phosphatase activity, as observed for pNPP, assays were performed in the presence of 25 mM MgCl 2 . In contrast to the pNPP results, similar quantities of inorganic phosphate were released, regardless of the metal used, with the exception of the P-Thr substrate, for which Mn 2ϩ was preferred over Mg 2ϩ . Taken together, rCTL0511 demonstrates metal-dependent substrate specificity, dephosphorylating the P-Thr peptide substrate most efficiently with the Mn 2ϩ cofactor. Phosphopeptide assays also were performed with the D38N and D199N mutant proteins ( Fig. 6B and C) . These mutations severely compromised the activity of rCTL0511. D38N and D199N mutations resulted in a 79% and 82% reduction in phosphatase activity with the P-Thr peptide substrate, respectively. Similarly, a 54% and 75% reduction in activity was observed with the P-Ser peptide substrate, respectively. The catalytic activity toward the phosphotyrosine peptide substrates also was reduced compared to the wild type (WT). Phosphate released from RRLI EDAE(pY)AARG peptide substrate and TSTEPQ(pY)QPGENL peptide substrate decreased by 56% and 59% with the D38N mutant, respectively, and 90% and 84% with the D199N mutant, respectively.
Phosphatase activity in EB and RB lysates. The differential (C) Phosphatase activity was measured over a pH of 7 to 10 in the presence of 0.5 mM MnCl 2 with 10 mM pNPP. All assays were performed at 37°C, and the data represent the average specific activity Ϯ standard error (SE) of the results from at least three independent experiments. Statistical analysis was performed using two-way analysis of variance (ANOVA) (*, significant difference, P Ͻ 0.05).
FIG 3 Kinetic analysis of rCTL0511. Initial reaction velocities were measured
at various pNPP concentrations (0.02 to 50 mM) using 3 g of protein in the presence of saturating levels of MnCl 2 (20 mM). Kinetic constants were determined by nonlinear regression analysis using the GraphPad Prism 5 software and are reported in Table 1 . The data represent the average specific activity Ϯ SE of the results from at least three independent experiments.
expression of phosphoproteins between C. caviae EB and RB forms and the presence of panchlamydial Hanks'-type kinases suggests that protein dephosphorylation may occur in both the EB and RB forms. Consequently, we sought to determine whether EBs and RBs contained phosphatase activity (representative EB and RB protein preparations are shown in Fig. S2 in the supplemental material). Since the turbidity of EB lysates interfered with A 405 readings used to measure pNPP hydrolysis, a fluorescent substrate, MUP, was used as an alternative assay for phosphatase activity in chlamydial lysates. EB and RB lysates (50 and 100 g) were transferred to a 96-well plate and assayed for phosphatase activity using 1 mM MUP. Phosphatase activity was detected for both chlamydial lysates (Fig. 7A ) and rCTL0511 (Fig. 7B) , supporting the presence of phosphatase activity in both the EB and RB forms.
DISCUSSION
Bacteria possess numerous posttranslational mechanisms to regulate essential cellular functions (49) . Reversible phosphorylation, the rapid modulation of a target protein through the interplay of protein kinase and phosphatase partners, has been shown to mediate multiple processes in bacteria (15, 16, (50) (51) (52) (53) . While Ser/Thr phosphatases are not as well understood as the Hanks'-type kinases, there is a clear need for dedicated phosphatases, as phosphorylated Ser/Thr residues are not as labile as phosphorylated Asp/His residues (54). Bacterial Ser/Thr protein kinases and cognate phosphatases, typically encoded in the same operon, have been identified in numerous bacteria and have been shown to be involved in stress responses, cell division, virulence, cell development, and antibiotic resistance (11) . The catalytic domain of PP2Cs consists of a single common core of 290 amino acids (29) . An examination of the primary structure of CTL0511 reveals homology with bacterial PP2Cs, along with the presence of the conserved features of the PP2C family of phosphatases, including all 11 signature motifs and eight absolutely conserved residues that are implicated in metal coordination, substrate recognition, and catalysis. Based on crystal structures and mutagenesis studies of numerous PP2Cs, four invariant aspartate residues (D23, D38, D199, and D238) are responsible for the coordination of the two active-site divalent cations, two Mn 2ϩ and/or Mg 2ϩ ions (14, 28, 30, 32, 38) . Mutation of these residues 
FIG 4
Phosphatase activity of rCTL0511 point mutants. The D38N and D199N rCTL0511 mutants were tested for phosphatase activity using pNPP as a substrate. Reactions were performed at 37°C in the presence of 25 mM MnCl 2 . The data represent the average specific activity Ϯ SE of the results from at least three independent experiments.
FIG 5
Effect of inhibitors on phosphatase activity. rCTL0511 was incubated with okadaic acid (OA) (17) , cyclosporine (CsA), or sodium pyrophosphate (SPP), and phosphatase activity was assayed at 37°C with 25 mM MnCl 2 and pNPP as a substrate. Relative activity was calculated as the percentage of activity remaining in the presence of the inhibitor versus the activity in assay buffer containing DMSO. The data represent the average relative activity Ϯ SE of the results from at least three independent experiments. Statistical analysis was performed using one-way ANOVA (*, significant difference, P Ͻ 0.05; N.S., not significant).
(D38N and D199N) in CTL0511 significantly reduced phosphatase activity with pNPP and synthetic phosphopeptide substrates, possibly due to the loss of electrostatic interactions between Asp and the divalent cations. Another hallmark feature of the PP2C family is resistance to okadaic acid (44) . rCTL0511 demonstrated resistance to both okadaic acid (PP1 and PP2A inhibitor) and cyclosporine (PP3 inhibitor) at concentrations well above their respective IC 50 s (49 nM to 147 nM for PP1, 0.28 nM to 4.7 nM for PP2A, and 10 nM to 40 nM for PP3). In contrast, phosphatase activity was completely abrogated in the presence of sodium pyrophosphate, a general Ser/Thr phosphatase inhibitor. Similar to other bacterial phosphatases, rCTL0511 displayed divalent cation dependent activity that was optimal at alkaline pH levels (34, 37, 39) , a K m of 0.95 Ϯ 0.21 mM pNPP, and a k cat of 8.4 Ϯ 0.40 s
Ϫ1
( Table 1 ). In addition, significant phosphatase activity was detected at the physiological pH (pH 7.2 to 7.4) encountered within the chlamydial cytoplasm (36). As previously described, PP2Cs are metal-dependent Ser/Thr protein phosphatases. Consistent with genome annotation, rCTL0511 was capable of dephosphorylation of P-Ser and P-Thr peptides in the presence of either Mn 2ϩ or Mg 2ϩ . The dephosphorylation of the P-Thr peptide was 2-fold greater in the presence of Mn 2ϩ compared to the P-Ser and P-Tyr peptides in the presence of either Mn 2ϩ or Mg 2ϩ , suggesting that metal utilization may dictate substrate preference or affinity. Metal-dependent substrate specificity has been shown in other PP2C phosphatases. For instance, Pph1 and PrpZ from Myxococcus xanthus and Salmonella enterica serovar Typhi, respectively, dephosphorylate PThr residues more effectively in the presence of Mn 2ϩ rather than Mg 2ϩ , while human phosphatases, PP2C␣ and Wip1, are more effective with Mg 2ϩ (34, 35, 55) . The differences in metal-dependent substrate preference may be attributed to the varied submotif regions or the chemical properties of the bound divalent metal ion, which may also explain the strict Mn 2ϩ requirement for hydrolysis of pNPP (31, 56) . While metal ion homeostasis and regulation are poorly understood in Chlamydia, enteric bacteria are known to maintain Mn 2ϩ and Mg 2ϩ concentrations between 10 and 100 M and Ͼ10 mM, respectively, despite relatively low extracellular concentrations (Ͻ4 M Mn 2ϩ in tissues and 0.5 mM Mg 2ϩ in the cytosol of mammalian cells) (57) (58) (59) . These bacteria have uptake systems that can elevate Mn 2ϩ levels above a concentration of 300 M (60). In Chlamydia, MgtE (CT194/CTL0446) is the most likely Mg 2ϩ transporter, while the manganese transporter remains unknown. YtgABCD (CT067 to CT070/CTL0323 Aspartate-to-asparagine point mutants (D38N and D199N) were incubated with either a P-Ser or P-Thr peptide substrate (B) and the P-Tyr peptide substrates (C) in the presence of 25 mM MnCl 2 . Phosphatase activity was determined using a malachite green endpoint assay to measure the amount of free phosphate (P i ). Assays were performed at 37°C for 60 min. Values from matched MBP-negative control assays performed with each peptide were subtracted from the corresponding rCTL0511 assay. The corrected values are shown. Statistical analysis was performed using two-way ANOVA (*, significant difference, P Ͻ 0.05; N.S., not significant). The data represent the average Ϯ SE of the results from at least three independent experiments.
FIG 7
Phosphatase activity of chlamydial lysates and rCTL0511 toward MUP substrate. Phosphatase assays were performed with EB and RB lysates (A) and rCTL0511 (B) in the presence of 1 mM MUP and 25 mM MnCl 2 . Chlamydial lysates (50 g and 100 g) and purified protein (1 g) were transferred to a 96-well plate, and reactions were initiated by adding 2ϫ and 1ϫ assay buffer, respectively. All assays were performed at 37°C, and MUP cleavage was monitored using an excitation and emission wavelengths of 360 nm and 440 nm, respectively. The data represent the average Ϯ SD of the results from at least two independent experiments. to CTL0326), annotated as a Mn 2ϩ /Zn 2ϩ ABC metal transporter, has been shown to prefer iron over manganese (61) . Taken together, it is plausible that Chlamydia spp. regulate intracellular metal concentrations, which in turn serve to modulate enzyme activity.
In prokaryotes, reversible tyrosine phosphorylation, typically mediated by BY kinases and protein tyrosine phosphatases (PTPs), regulates exopolysaccharide production, DNA metabolism, and virulence (62) (63) (64) . BY kinases are either membranebound proteins or cytosolic proteins associated with the membrane, while PTPs can be secreted or function intracellularly. Both PTPs and BY kinases are noticeably absent in Chlamydia species (65) . While several bacterial PP2Cs have been shown to mediate P-Tyr dephosphorylation in vitro, the biological relevance of PP2C-mediated tyrosine dephosphorylation remains unknown, and the need for a tyrosine phosphatase in C. trachomatis is unclear (34, 37, 66) . In Chlamydia, the Hanks'-type kinases PknD and Pkn1 have been functionally validated in C. trachomatis and C. pneumoniae (PknD only) (19, 20) . While PknD and Pkn1 from C. trachomatis were found to phosphorylate only Ser and Thr, the C. pneumoniae PknD could also phosphorylate Tyr. Further supporting Tyr phosphorylation among the Chlamydiae, "Candidatus Protochlamydia amoebophila," Waddlia chondrophila, Parachlamydia acanthamoebae, and Simkania negevensis, which have genomes ϳ2-fold larger than the Chlamydia genomes, all encode PTPs, while "Ca. Protochlamydia amoebophila" and W. chondrophila encode both PTPs and BY kinases (67) . Broadening of the substrate specificity of the chlamydial Hanks'-type kinases and Ser/Thr protein phosphatase to allow for interactions with (P-)Tyr may have allowed for the loss of PTPs and BY kinases during reductive evolution of the chlamydial genomes. Such a pathway would mirror the evolution of the chlamydial nucleotide transporters, which are fewer and have broader substrate preferences than the chlamydial ancestors (68, 69) . In light of the broad substrate specificities of CTL0511 and the C. pneumoniae PknD, the tyrosine phosphorylation capabilities of PknD and Pkn1 from C. trachomatis should be reassessed. This is the first study of a "generalist" PP2C from C. trachomatis. RsbU, a sensor phosphatase that functions within the context of a partner-switching mechanism, contains a PP2C domain that has been shown to dephosphorylate a P-Ser within the anti-antisigma factor RsbV1 (70) . The defined role of RsbU makes it unlikely to serve as a cognate phosphatase for Pkn1 or PknD. While the physiological role of CTL0511 has not been determined, we hypothesize that it mediates dephosphorylation of Pkn1 and PknD substrates and may play a role in regulating processes involved in chlamydial development. Ser/Thr protein phosphatases and Hanks'-type kinases are typically encoded together and work as partners to mediate reversible phosphorylation of protein substrates. In contrast to other bacteria, the genes encoding Pkn1 (ctl0400), PknD (ctl0553), and CTL0511 are not organized as an operon. Instead, ctl0400, ctl0553, and ctl0511 are dispersed throughout the genome in operons with genes encoding proteins with putative and/or unknown functions. While this atypical gene organization appears to preclude an obvious association between protein kinase and phosphatase pairs and substrates, precedence for scattering the genes of cofunctional modules throughout the genome exists in Chlamydia, as exemplified by the type III secretion system components (71) . In terms of gene expression, CT145 (CTL0400 homolog) and CT301 (CTL0553 homolog) transcripts are detectable by 8 and 3 h postinfection (h.p.i.), respectively. CT259 (CTL0511 homolog) transcripts are also present by 8 h.p.i., possibly expressed together with CT258 (CTL0510), and peak at 24 h.p.i., coinciding with RB-to-EB conversion (72) . The overlap in kinase and phosphatase expression profiles supports interplay between these enzymes.
Phosphatase activity was detected in EB and RB lysates. The presence of numerous phosphoproteins in EBs and their general paucity in RBs based on the prior C. caviae study suggest that protein dephosphorylation may play an important role in early infection steps and/or EB-to-RB conversion, possibly through the activation of proteins required for morphogenesis and/or various metabolic processes (21) . Of note, numerous proteins involved in central metabolism and protein synthesis were identified in the C. caviae EB phosphoproteome but not the RB phosphoproteome. Consistent with this hypothesis, phosphatase activity was detected in EB lysates. In addition, the presence of PknD and Pkn1 transcripts concomitant with the RB stage of growth and the detection of phosphorylated proteins in the RB form likely lead to a requirement for phosphatases in the RB stage. While the presence of phosphatase activity in both EB and RB lysates supports a role for CTL0511 during both stages of development, the absence of PP2C-specific inhibitors or CTL0511 mutants prevented us from directly linking the phosphatase activity in EB and RB lysates to CTL0511.
Collectively, our results demonstrated that rCTL0511 functions as a PP2C phosphatase capable of dephosphorylating P-Ser, P-Thr, and P-Tyr. In addition, rCTL0511 displayed Mn 2ϩ -dependent hydrolysis of pNPP at physiological pH (7.2 to 7.4), while dephosphorylation of P-Ser, P-Thr, and P-Tyr peptides occurred in the presence of either Mn 2ϩ or Mg 2ϩ , indicating that metal type can affect substrate preference. Amino acid sequence analysis, mutagenesis studies, and inhibitor sensitivity assays further support the designation of CTL0511 as a PP2C, for which we propose the nomenclature of Chlamydia protein phosphatase 1 (Cpp1). The validation of a protein phosphatase with broad substrate specificity further supports protein phosphorylation as a regulatory mechanism within Chlamydia. Consistent with PknD inhibitor studies that demonstrated the essentiality of protein phosphorylation for chlamydial growth, we have been unable to obtain ctl0511 insertion mutants using a group II intron mutagenesis approach (73) , and Kokes et al. did not obtain nonsense ctl0511 mutants using a high-content chemical mutagenesis approach (23) . Future studies will focus on identifying CTL0511 inhibitors and substrates to further query the physiological role of protein phosphorylation in Chlamydia.
